The CDC analysis suggests the shots will reduce the burden of RSV on hospitals in the fall.
The analysis found that vaccinating one million adults 65 and older with a single dose ofRSV season typically lasts from October to March in the Northern Hemisphere.GSK's shotThe estimated number of prevented outcomes is lower for adults ages 60 to 64, according to the CDC medical officer, Dr. Michael Melgar. He said that's because there's "less existing RSV disease" in that group for the vaccine to prevent.
Each year, RSV hospitalizes 60,000 to 160,000 older adults and kills 6,000 to 10,000, according to CDCPfizer and GSK on Wednesday both presented longer-term efficacy data at the meeting, which suggested that their shots generally maintain some protection against RSV after one season of the virus. The analysis also suggests that the shots could reduce the burden of RSV on hospitals in the fall, when multiple respiratory viruses usually begin to spread at high levels.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US CDC advisers recommend older adults may receive Pfizer, GSK shots for RSVA panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended that new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections be available to older adults in the U.S. but stopped short of saying all of them should get the shots.
Read more »
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and olderThe CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
Read more »
RSV Vaccine For Adults Gives Long-Term Protection, GSK Says After Late-Stage TrialDrugmaker GSK said its RSV vaccine gave long-term protection in older adults after a single shot, according to results from its late stage clinical trial.
Read more »
CDC vaccine advisers’ vote sets stage for first RSV shot for older adults this fall | CNNAdults 60 and older will be eligible to get a shot that could protect them from respiratory syncytial virus, or RSV, this fall if the US Centers for Disease Control and Prevention follows the advice of its independent vaccine advisory committee.
Read more »
Pfizer RSV vaccine for older adults is only slightly less effective after 18 monthsPfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the shot should be administered in the U.S.
Read more »
Pfizer RSV vaccine for older adults is slightly less effective after 18 monthsPfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the shot should be administered in the U.S.
Read more »